Kara Melmed and Chitra Venkatasubramanian discuss optimal blood pressure targets following intracerebral hemorrhage in this interview episode.
27 Feb 2025
Advancing the awareness and management of rare neurological disorders: ALSP, PKU, CADASIL, SSADHD, & rare epilepsies
Welcome to today’s podcast, which focuses on the understanding and management of rare brain disorders. This episode, in honor of...
28 Nov 2024
Updates to the McDonald diagnostic criteria for MS
Dr. Ian McDonald and Dr. Bianca Weinstock-Guttman present updates to the McDonald diagnostic criteria for MS, enabling more accurate and timely diagnoses for patients worldwide.
30 Oct 2024
Updates on managing augmentation in RLS from Sleep Europe 2024
Dopaminergic medications have been widely used in the treatment of restless legs syndrome (RLS), where they are effective at reducing...
9 Aug 2024
ALS Gene Therapy Insights with Prof. Dame Pamela Shaw
In recent years, genetic therapies have garnered much attention for their potential to modify the underlying pathological processes in neurological...
The post ALS Gene Therapy Insights with Prof. Dame Pamela Shaw (https://www.vjneurology.com/podcast/als-gene-therapy-insights-with-prof-dame-pamela-shaw/) appeared first on VJNeurology (https://www.vjneurology.com).
25 Jul 2024
Navigating Status Epilepticus: Breakthroughs in Management
In this episode, we delve into the complexities of managing status epilepticus, particularly the refractory stages that resist initial treatments....
The post Navigating Status Epilepticus: Breakthroughs in Management (https://www.vjneurology.com/podcast/navigating-status-epilepticus-breakthroughs-in-management/) appeared first on VJNeurology (https://www.vjneurology.com).
20 Apr 2024
Breaking the Cycle: Debating Management Approaches in Medication Overuse Headache
Medication-overuse headache (MOH) is a neurological disorder, affecting 1% of the general population. It plays a huge role in transforming...
The post Breaking the Cycle: Debating Management Approaches in Medication Overuse Headache (https://www.vjneurology.com/podcast/breaking-the-cycle-debating-management-approaches-in-medication-overuse-headache/) appeared first on VJNeurology (https://www.vjneurology.com).
5 Apr 2024
Examining evidence for EVT in MeVO stroke
The latest guidelines recommend endovascular thrombectomy (EVT) as the gold standard treatment approach for eligible patients with an acute ischemic...
The post Examining evidence for EVT in MeVO stroke (https://www.vjneurology.com/podcast/examining-evidence-for-evt-in-mevo-stroke/) appeared first on VJNeurology (https://www.vjneurology.com).
22 Mar 2024
Decoding epilepsy: a precision approach to management
Over the past decade, a genomic revolution has unfolded in medicine, and the epilepsy space is no exception. The intricacies...
The post Decoding epilepsy: a precision approach to management (https://www.vjneurology.com/podcast/decoding-epilepsy-a-precision-approach-to-management/) appeared first on VJNeurology (https://www.vjneurology.com).
16 Jan 2024
Cluster headache management: current landscape & emerging therapies
Cluster headache, a rare and severe form of headache disorder, represents the most common trigeminal autonomic cephalalgia. Due to its...
The post Cluster headache management: current landscape & emerging therapies (https://www.vjneurology.com/podcast/cluster-headache-management-current-landscape-emerging-therapies/) appeared first on VJNeurology (https://www.vjneurology.com).
20 Dec 2023
Evolving perspectives in MOGAD: a comprehensive research update
Myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD) is characterized by relapsing episodes of severe immune-mediated demyelination in deep white matter tracts....
The post Evolving perspectives in MOGAD: a comprehensive research update (https://www.vjneurology.com/podcast/evolving-perspectives-in-mogad-a-comprehensive-research-update/) appeared first on VJNeurology (https://www.vjneurology.com).
9 Aug 2023
Artificial intelligence: a new era in neurology
The integration of artificial intelligence (AI) into the field of neurology has opened the door to unprecedented advancements. From facilitating...
The post Artificial intelligence: a new era in neurology (https://www.vjneurology.com/podcast/artificial-intelligence-a-new-era-in-neurology/) appeared first on VJNeurology (https://www.vjneurology.com).
2 Aug 2023
The wearables revolution in neurology
Neurologists and researchers are increasingly harnessing the power of wearables to gather real-time, high-quality data about patients’ neurological conditions. From...
The post The wearables revolution in neurology (https://www.vjneurology.com/podcast/the-wearables-revolution-in-neurology/) appeared first on VJNeurology (https://www.vjneurology.com).
25 Jul 2023
α-syn in Parkinson’s disease: cause, biomarker, and treatment target
The causative nature of alpha-synuclein (α-syn) accumulation in Parkinson’s disease pathophysiology has been a subject of debate among researchers, ever...
The post α-syn in Parkinson’s disease: cause, biomarker, and treatment target (https://www.vjneurology.com/podcast/%ce%b1-syn-in-parkinsons-disease-cause-biomarker-and-treatment-target/) appeared first on VJNeurology (https://www.vjneurology.com).
29 Mar 2023
Biomarkers for disease progression and treatment response in MS
Biomarker development and discovery have been an important point in multiple sclerosis (MS) research for many years. Neurofilament light (NfL)...
The post Biomarkers for disease progression and treatment response in MS (https://www.vjneurology.com/podcast/biomarkers-for-disease-progression-and-treatment-response-in-ms/) appeared first on VJNeurology (https://www.vjneurology.com).
10 Mar 2023
Debating bridging thrombolysis at ISC 2023
Whether the addition of intravenous thrombolysis (IVT) adds benefit beyond what can be achieved with mechanical thrombectomy (MT) alone is...
The post Debating bridging thrombolysis at ISC 2023 (https://www.vjneurology.com/podcast/debating-bridging-thrombolysis-at-isc-2023/) appeared first on VJNeurology (https://www.vjneurology.com).
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Podcast Authority Score: 18 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
26
Social presence
0
YouTube
0
Engagement
27
Contact VJNeurology Podcast
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
